SCHEMBL23905549

SCHEMBL23905549

O=C(O)c1cc(OC2CC2)c2nc(C(F)F)sc2c1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 16/20 0.40
ACACB O00763 1/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905554 0.89 ACACB (0.42) NR1H4ACACB
SCHEMBL23905542 0.87 ACACB (0.39) ACACBKMT2A
SCHEMBL23905899 0.80 NR1H4 (0.41) NR1H4KMT2A
SCHEMBL22672605 0.73 TOP2A (0.40) NR1H4ACACB
SCHEMBL23904848 0.72 KMO (0.37) KMT2A
SCHEMBL22672569 0.71 CA12 (0.45) NR1H4
SCHEMBL22672718 0.70 TOP2A (0.41) NR1H4KMT2A
SCHEMBL22672407 0.70 NR1H4 (0.38) NR1H4
SCHEMBL25114764 0.70 KMT2A (0.36) ACACBKMT2A
SCHEMBL20833630 0.70 NPC1 (0.43) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed